Different Kinetics of HBV-DNA and HBsAg in HCV Coinfected Patients during DAAs Therapy

Direct-acting antivirals (DAAs) for hepatitis C virus (HCV) may induce hepatitis B virus (HBV) reactivations in co-infected patients, whose dynamics and outcomes could depend on the phase of HBV infection. We investigated HBsAg and HBV-DNA kinetics in fifteen untreated HBeAg Negative Infection (ENI)...

Descripción completa

Detalles Bibliográficos
Autores principales: Colombatto, Piero, Palmisano, Elena, Ricco, Gabriele, Cavallone, Daniela, Oliveri, Filippo, Coco, Barbara, Salvati, Antonio, Romagnoli, Veronica, Surace, Lidia, Vatteroni, Marialinda, Pistello, Mauro, Virdis, Agostino, Bonino, Ferruccio, Brunetto, Maurizia Rossana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911219/
https://www.ncbi.nlm.nih.gov/pubmed/35268497
http://dx.doi.org/10.3390/jcm11051406

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911219/
https://www.ncbi.nlm.nih.gov/pubmed/35268497
http://dx.doi.org/10.3390/jcm11051406

Ejemplares similares